Business News | US FDA Grants the Coveted Breakthrough Designation for Early-stage Prostate Cancer Detection Blood Test Developed in India by Datar Cancer Genetics
Get latest articles and stories on Business at LatestLY. Datar Cancer Genetics today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation' for its blood test to detect early-stage prostate cancer. This is the second test from the Company that has received the Breakthrough Device Designation from the US FDA. Late last year, the company's breast cancer detection test became the first such test to receive the designation. Business News | US FDA Grants the Coveted Breakthrough Designation for Early-stage Prostate Cancer Detection Blood Test Developed in I...
Source: latestly.com